| Name | Title | Contact Details |
|---|
Prime Case LLC is a leading provider of lawsuit funding and lawsuit advances for those expecting a cash settlement resulting from a pending lawsuit, verdict or judgment. The need for our legal funding & settlement funding service arises from the fact that the legal process is often slow and many plaintiffs simply cannot afford to wait for a fair settlement due to financial pressures. Prime Case LLC works directly with attorneys and paralegals nationwide to provide their clients with immediate financial help. Our attorney-focused, the plaintiff funding process is the simple, fast, and cost-effective way to fund your clients. Here at Prime Case Funding, we want to save both you and your staff time to focus on getting your client the largest case settlement possible. Referring Your Clients to Prime Case Funding means: 1. Simple Application 2. Minimal Paperwork 3.No Case Interference 4. Consistent Funding Agreements 5. Quick Funding Turnaround 6. Low Funding Rates Prime Case LLC will limit funding to 10%-15% of the case value, to ensure your ability to settle the case will not be compromised. In our experience, plaintiff funding never affects attorney fees or the way your firm handles the case.
Purposeful Design is a Christian ministry that exists to help rebuild lives of individuals who have struggled with addiction, homelessness, incarceration and other obstacles; to equip them with valuable work skills; and to provide the gift of work (Genesis 2:15, Matthew 28:16-20, Ephesians 2:8-10).
At Mako Fire Group our main goal is helping you protect what matters most, and we take great pride in that. Our companies highly qualified technicians undergo a rigorous training surpassing what is required of them from local and state governments to ensure the highest level of satisfaction for our customers. Offering a wide array of cutting edge products including fire extinguishers, exit and emergency lights, smoke detection/alarms, etc. we are your one stop shop for fire prevention and protection. Annual services for commercial properties include Fire extinguisher maintenance, smoke alarm maintenance, emergency lighting maintenance, fire alarm maintenance, sprinkler maintenance, etc. With a corporate sized workforce and mom-and-pop style customer service, we at Mako Fire Group guarantee we will meet and exceed all your expectations.
Monica Massey is a high energy motivational speaker with a reputation for energizing and inspiring audiences of all sizes. Whether youre looking to motivate your team, inspire your community, or ignite attendees at a conference, Monica will deliver a powerful message that will leave a lasting impact. Using healthy doses of "real talk" and relatable humor, Monica brings her no-nonsense self to stage to make audiences laugh, cheer and leave feeling inspired and empowered. Available for keynote presentations, panels, workshops/breakouts and serving as emcee. If youre looking for a dynamic speaker whos guaranteed to bring some serious energy to your meeting or program, look no further. Topics include: • Innovate or Die • Getting DEI Right • Build Your Own Table: Women in the workplace • Leaders Dont Always Get Leadership Right • Adopting a Move It Mindset • Eat the Elephant in the Room: Dealing with Crisis • Words Matter: Effective communications
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.